X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
butyrates - pharmacology (4802) 4802
animals (3801) 3801
science & technology (3376) 3376
life sciences & biomedicine (3215) 3215
humans (2963) 2963
rats (1425) 1425
butyric acid (1412) 1412
male (1397) 1397
mice (1075) 1075
female (1004) 1004
cell line (898) 898
butyrates - metabolism (745) 745
biochemistry & molecular biology (727) 727
butyrate (641) 641
sodium butyrate (629) 629
kinetics (613) 613
cells, cultured (606) 606
cell differentiation - drug effects (593) 593
oncology (550) 550
tumor cells, cultured (542) 542
pharmacology & pharmacy (541) 541
cell biology (503) 503
butyrates (497) 497
dose-response relationship, drug (488) 488
time factors (484) 484
in vitro techniques (476) 476
cell division - drug effects (474) 474
apoptosis - drug effects (443) 443
cyclic amp - pharmacology (442) 442
esters (436) 436
apoptosis (386) 386
cell line, tumor (380) 380
histones - metabolism (351) 351
enzyme inhibitors - pharmacology (341) 341
gene expression (341) 341
histone deacetylase inhibitors (334) 334
acetylation (324) 324
research (316) 316
research article (308) 308
abridged index medicus (305) 305
hydrogen-ion concentration (302) 302
fatty acids (291) 291
propionates - pharmacology (272) 272
chemistry (265) 265
hydroxamic acids - pharmacology (263) 263
rna, messenger - metabolism (260) 260
proteins (254) 254
butyrates - chemistry (251) 251
analysis (248) 248
gene expression regulation - drug effects (242) 242
drug synergism (231) 231
sodium (230) 230
butyric acid - pharmacology (228) 228
histone deacetylase inhibitors - pharmacology (226) 226
structure-activity relationship (223) 223
cell survival - drug effects (218) 218
physiological aspects (217) 217
butyrates - therapeutic use (214) 214
antineoplastic agents - pharmacology (213) 213
cell differentiation (213) 213
neurosciences (211) 211
rats, sprague-dawley (210) 210
transfection (208) 208
stimulation, chemical (207) 207
acetates - pharmacology (206) 206
blotting, western (206) 206
cell proliferation - drug effects (204) 204
liver - drug effects (204) 204
liver - metabolism (203) 203
neurosciences & neurology (202) 202
rna, messenger - genetics (200) 200
butyrates - administration & dosage (199) 199
old medline (198) 198
adult (197) 197
cell cycle - drug effects (197) 197
nutrition & dietetics (196) 196
carbon isotopes (190) 190
diet (190) 190
immunology (190) 190
cattle (186) 186
physiology (186) 186
biotechnology & applied microbiology (184) 184
molecular sequence data (184) 184
bucladesine - pharmacology (181) 181
physical sciences (181) 181
tetradecanoylphorbol acetate - pharmacology (181) 181
colon - metabolism (179) 179
colonic neoplasms - pathology (176) 176
rabbits (176) 176
acetates - metabolism (172) 172
differentiation (172) 172
fermentation (171) 171
flow cytometry (171) 171
cancer (170) 170
cell cycle (170) 170
histone deacetylases - metabolism (170) 170
dimethyl sulfoxide - pharmacology (168) 168
glucose - metabolism (168) 168
mice, inbred c57bl (168) 168
theophylline - pharmacology (168) 168
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6675) 6675
Japanese (143) 143
French (80) 80
German (76) 76
Russian (67) 67
Italian (53) 53
Chinese (52) 52
Spanish (9) 9
Portuguese (8) 8
Polish (7) 7
Czech (3) 3
Ukrainian (2) 2
Hebrew (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of physiology. Regulatory, integrative and comparative physiology, ISSN 0363-6119, 01/2013, Volume 304, Issue 1, pp. R23 - R32
The interaction between adenosine and soluble epoxide hydrolase (sEH) in vascular response is not known. Therefore, we hypothesized that lack of sEH in mice... 
Relaxation | CYP2J5-epoxgenase;ω-hydroxylase | receptor | Soluble epoxide hydrolase | Contraction | Adenosine A | Epoxide Hydrolases - physiology | Adenosine-5'-(N-ethylcarboxamide) - pharmacology | Butyrates - pharmacology | Male | Receptor, Adenosine A2A - physiology | Lauric Acids - pharmacology | Vasodilation - genetics | 8,11,14-Eicosatrienoic Acid - analogs & derivatives | Adenosine A2 Receptor Agonists - pharmacology | Urea - analogs & derivatives | Female | Benzamides - pharmacology | Oxygenases - physiology | Vasodilation - physiology | 8,11,14-Eicosatrienoic Acid - pharmacology | Adamantane - analogs & derivatives | NG-Nitroarginine Methyl Ester - pharmacology | Adamantane - pharmacology | Triazines - pharmacology | Phenethylamines - pharmacology | Vasodilator Agents - pharmacology | Enzyme Inhibitors - pharmacology | Gene Silencing | Adenosine - pharmacology | Pyrimidines - pharmacology | Epoxide Hydrolases - genetics | Triazoles - pharmacology | Adenosine A2 Receptor Antagonists - pharmacology | PPAR gamma - physiology | Animals | Adenosine - analogs & derivatives | Benzoates - pharmacology | Mice | Phenylurea Compounds - pharmacology | Pyridines - pharmacology | Vasodilation - drug effects | Urea - pharmacology | Index Medicus | adenosine A2a receptor | CYP2J5-epoxgenase | ω-hydroxylase | relaxation | contraction | Cardiovascular and Renal Integration | soluble epoxide hydrolase | adenosine A1 receptor
Journal Article
Naunyn-Schmiedeberg's archives of pharmacology, ISSN 0028-1298, 4/2009, Volume 379, Issue 4, pp. 325 - 336
Journal Article
Psychopharmacology, ISSN 0033-3158, 5/2009, Volume 203, Issue 4, pp. 781 - 792
Journal Article
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 06/2007, Volume 321, Issue 3, pp. 892 - 901
Journal Article
Investigational new drugs, ISSN 0167-6997, 2/2012, Volume 30, Issue 1, pp. 25 - 36
Nutlin-3, a small-molecule MDM2 inhibitor, restores p53 function and is, thus, an appealing candidate for the treatment of cancers retaining wild-type p53.... 
Nutlin-3 | Medicine & Public Health | Histone deacetylase inhibitors | p53 acetylation | Paclitaxel | MDM2 | Oncology | MDM4 | Pharmacology/Toxicology | P53 acetylation | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Gene Expression Regulation, Enzymologic - drug effects | Proto-Oncogene Proteins c-mdm2 - genetics | Paclitaxel - pharmacology | Butyrates - pharmacology | Humans | Peptides, Cyclic - pharmacology | RNA, Messenger - metabolism | Tumor Suppressor Protein p53 - genetics | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Flow Cytometry | Neoplasms - genetics | Benzamides - pharmacology | Acetylation | Cell Death - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Nuclear Proteins - genetics | Hydroxamic Acids - pharmacology | Proto-Oncogene Proteins c-mdm2 - antagonists & inhibitors | Proto-Oncogene Proteins c-mdm2 - metabolism | Real-Time Polymerase Chain Reaction | Proto-Oncogene Proteins - metabolism | Down-Regulation | Tumor Suppressor Protein p53 - metabolism | Neoplasms - enzymology | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Imidazoles - pharmacology | Piperazines - pharmacology | Blotting, Western | Drug Synergism | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Pyridines - pharmacology | Neoplasms - pathology | Physiological aspects | Genetic aspects | Dosage and administration | Drug therapy | Gene expression | Cancer | Studies | Pharmacology | Inhibitor drugs | Cancer therapies | Tumors | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 02/2002, Volume 99, Issue 5, pp. 2995 - 3000
Suberoylanilide hydroxamic acid (SAHA) is a hydroxamic acid-containing hybrid polar molecule; SAHA specifically binds to and inhibits the activity of histone... 
Biological Sciences | Messenger RNA | Antiinflammatories | Cytokines | Butyrates | Secretion | Cell lines | Histones | Mice | Macrophages | Tumors | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Leukocytes, Mononuclear - metabolism | Mitogens - pharmacology | Concanavalin A - pharmacology | Humans | Antineoplastic Agents - administration & dosage | RNA, Messenger - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Enzyme Inhibitors - administration & dosage | Liver - injuries | Liver - drug effects | Hydroxamic Acids - administration & dosage | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Cytokines - genetics | Hydroxamic Acids - pharmacology | Macrophages, Peritoneal - drug effects | Hepatocytes - drug effects | Interleukin-12 - biosynthesis | Nitric Oxide - biosynthesis | Leukocytes, Mononuclear - drug effects | Cytokines - metabolism | Interferon-gamma - secretion | Tumor Necrosis Factor-alpha - secretion | Cells, Cultured | Enzyme Inhibitors - pharmacology | CD3 Complex - metabolism | Cell Division - drug effects | Tumor Necrosis Factor-alpha - pharmacology | Animals | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Lipopolysaccharides - pharmacology | Leukocytes, Mononuclear - cytology | Histone Deacetylase Inhibitors | Mice, Inbred BALB C | Macrophages, Peritoneal - metabolism | Interleukin-1 - secretion | Interferon-gamma - pharmacology | Usage | Immunocytochemistry | Physiological aspects | Inflammation | Research | Liver cells | Immunology | Genes | Immune system | lipopolysaccharides | suberoylanilide hydroxamic acid | histone deacetylase inhibitors | Index Medicus
Journal Article